The molecular aetiology of central obesity: moving from variant to function using large-scale data-driven approaches. (360G-Wellcome-221782_Z_20_Z)

£2,059,266

Central obesity is a leading contributing cause of illness and death across the world. Currently available strategies for prevention and treatment of this condition are manifestly inadequate. The research proposed here aims to identify fundamental processes involved in the development of central obesity. I plan to harness the power of human genetics, fused with deep molecular characterisation of the adipocytes to generate novel insights into the biology of central obesity. This ‘multi-omics’ approach will provide the basis for more effective preventative and therapeutic approaches that reduce the burden of central obesity and associated disease.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Region South East
Award Date 2020-12-01T00:00:00+00:00
Internal ID 221782/Z/20/Z
Planned Dates: End Date 2027-06-30T00:00:00+00:00
Planned Dates: Start Date 2021-07-01T00:00:00+00:00
Amount Awarded 2059266
Financial Year 2020/21
Lead Applicant Dr Duncan Stuart Sinclair Palmer
Grant Programme: Title Residual Award
Applicant Surname Palmer
Approval Committee Science Interview Panel
Recipient Org: Country United Kingdom
Recipient Org: City Oxford
Has the grant transferred? No
Research conducted at multiple locations? No
Total amount including partnership funding 2059266

Help shape the next 10 years of GrantNav!

GrantNav is celebrating its 10th anniversary. Take our quick 3-minute survey to tell us how we can make the data work better for you.

Take the Survey